Authors: Parfrey, P

Citation: P. Parfrey, Anaemia in chronic renal disease: lessons learned since Seville 1994, NEPH DIAL T, 16, 2001, pp. 41-45

Authors: Pei, Y Paterson, AD Wang, KR He, N Hefferton, D Watnick, T Germino, GG Parfrey, P Somlo, S St George-Hyslop, P

Citation: Y. Pei et al., Bilineal disease and trans-heterozygotes in autosomal dominant polycystic kidney disease, AM J HU GEN, 68(2), 2001, pp. 355-363

Authors: Turner, CJ Parfrey, P Ryan, K Miller, R Brown, A

Citation: Cj. Turner et al., Community pharmacist outreach program directed at physicians treating congestive heart failure, AM J HEAL S, 57(8), 2000, pp. 747-752

Authors: Watnick, T He, N Wang, KR Liang, Y Parfrey, P Hefferton, D St George-Hyslop, P Germino, G Pei, Y

Citation: T. Watnick et al., Mutations of PKD1 in ADPKD2 cysts suggest a pathogenic effect of trans-heterozygous mutations, NAT GENET, 25(2), 2000, pp. 143-144

Authors: Pei, Y Watnick, T He, N Wang, KR Liang, Y Parfrey, P Germino, G St George-Hyslop, P

Citation: Y. Pei et al., Somatic PKD2 mutations in individual kidney and liver cysts support a "two-hit" model of cystogenesis in type 2 autosomal dominant polycystic kidney disease, J AM S NEPH, 10(7), 1999, pp. 1524-1529